Karvea var desuden genstand for to store undersøgelser vedrørende behandling af nyresygdom hos 2 326 patienter med type 2- diabetes.
For the treatment of kidney disease, Karvea was studied in two large studies involving a total of 2,326 patients with type 2 diabetes.